Weidle, U.H.* ; Dickopf, S.* ; Hintermair, C. ; Kollmorgen, G.* ; Birzele, F.* ; Brinkmann, U.*
The role of micro RNAs in breast cancer metastasis: Preclinical Validation and potential therapeutic targets.
Cancer Genomics Proteomics 15, 17-39 (2018)
Despite the approval of several molecular therapies in the last years, breast cancer-associated death ranks as the second highest in women. This is due to metastatic disease, which represents a challenge for treatment. A better understanding of the molecular mechanisms of metastasis is, therefore, of paramount importance. In this review we summarize the role of micro RNAs (miRs) involved in metastasis of breast cancer. We present an overview on metastasis-promoting, -suppressing and context-dependent miRs with both activities. We have categorized the corresponding miRs according to their target classes, interaction with stromal cells or exosomes. The pathways affected by individual miRs are outlined in regard to in vitro properties, activity in metastasis-related in vivo models and clinical significance. Current approaches that may be suitable for therapeutic inhibition or restauration of miR activity are outlined. Finally, we discuss the delivery bottlenecks which present as a major challenge in nucleic acid (miR)-based therapies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Colonization Of Distinct Organs ; Epithelial-mesenchymal Transition (emt) ; Exosomes ; Mesenchymal-epithelial Transition (met) ; Metastasis-related In Vivo Models ; Migration And Invasion ; Review ; Tumor Cell/stromal Cell Interactions
Keywords plus
Sprache
Veröffentlichungsjahr
2018
Prepublished im Jahr
2017
HGF-Berichtsjahr
2017
ISSN (print) / ISBN
1109-6535
e-ISSN
1790-6245
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 15,
Heft: 1,
Seiten: 17-39
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
International Institute of Anticancer Research
Verlagsort
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502890-001
Förderungen
Copyright
Erfassungsdatum
2018-01-24